Atlas Trials

Evaluation of Bile Acid Concentrations and Their Signaling as Markers of Testicular Tumorigenesis and Germ Cell Tumor Chemosensitivity

Clinical trial NCT07463508 · RECRUITING

Trial details

NCT number
NCT07463508
Sponsor
University Hospital, Clermont-Ferrand
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Testicular Germ Cell Cancer
Start date
2026-01-01
Primary completion
2029-01-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.